var data={"title":"Autoimmune hepatitis: Associated extrahepatic disorders","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Autoimmune hepatitis: Associated extrahepatic disorders</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/contributors\" class=\"contributor contributor_credentials\">Michael A Heneghan, MD, MMedSc, FRCPI</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/contributors\" class=\"contributor contributor_credentials\">Sanjiv Chopra, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/contributors\" class=\"contributor contributor_credentials\">Kristen M Robson, MD, MBA, FACG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 24, 2015.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Autoimmune hepatitis is a chronic hepatitis of unknown etiology characterized by immunologic and autoimmunologic features (see <a href=\"topic.htm?path=autoimmune-hepatitis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Autoimmune hepatitis: Clinical manifestations and diagnosis&quot;</a>). In the spectrum of autoimmune disease, classified from organ-specific to non-organ-specific, autoimmune liver diseases fall somewhere in the middle. The diseases are usually confined to the liver but can be associated with a number of other autoimmune diseases.</p><p>This topic will review the extrahepatic disorders associated with autoimmune hepatitis. The hepatic manifestations, diagnosis, and treatment of autoimmune hepatitis are discussed elsewhere. (See <a href=\"topic.htm?path=autoimmune-hepatitis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Autoimmune hepatitis: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=autoimmune-hepatitis-treatment\" class=\"medical medical_review\">&quot;Autoimmune hepatitis: Treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">OVERVIEW</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several extrahepatic disorders associated with autoimmune hepatitis (AIH) have been described (<a href=\"image.htm?imageKey=GAST%2F59606\" class=\"graphic graphic_table graphicRef59606 \">table 1</a>) and are seen in both type 1 and type 2 AIH (<a href=\"image.htm?imageKey=GAST%2F65135\" class=\"graphic graphic_table graphicRef65135 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/1-4\" class=\"abstract_t\">1-4</a>]. Concurrent immunologic diseases are more common with AIH than with viral hepatitis. One prospective study, for example, found that concurrent immunologic disease was present in 38 percent of 122 patients with AIH compared with 22 percent of 63 patients with chronic viral hepatitis [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/5\" class=\"abstract_t\">5</a>]. The nature of the extrahepatic diseases was the same in both groups.</p><p>The associated diseases may antedate the appearance of AIH or occur after the diagnosis of the liver disease is established. The clinical expression of the associated disease can be extremely variable and, at times, may even be occult and unrecognized unless specifically sought (such as measurement of antibodies to detect celiac disease or routine proctosigmoidoscopy for the detection of ulcerative colitis).</p><p>Concurrent extrahepatic autoimmune disorders associated with AIH include autoimmune thyroiditis, diabetes, rheumatoid arthritis, and ulcerative colitis (ranging from approximately 20 to 49 percent of patients with AIH in various reports from around the world) [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/1-4,6-12\" class=\"abstract_t\">1-4,6-12</a>]. Up to 43 percent of patients with AIH report a family history of another autoimmune disease in their first-degree relatives, commonly thyroid disease and type 1 diabetes [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/13\" class=\"abstract_t\">13</a>].</p><p class=\"headingAnchor\" id=\"H74170253\"><span class=\"h1\">EFFECT OF AIH CLASSIFICATION</span></p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Type 1 AIH</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common extrahepatic disorders associated with type 1 autoimmune hepatitis (AIH) are thyroiditis, Graves' disease, ulcerative colitis, celiac disease [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/6\" class=\"abstract_t\">6</a>], and rheumatoid arthritis [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/1-10\" class=\"abstract_t\">1-10</a>]. Ulcerative colitis is more typically associated with primary sclerosing cholangitis, but can be seen in AIH without any features of cholangitis (see <a href=\"topic.htm?path=primary-sclerosing-cholangitis-epidemiology-and-pathogenesis\" class=\"medical medical_review\">&quot;Primary sclerosing cholangitis: Epidemiology and pathogenesis&quot;</a>). In one study of 105 patients with AIH who had been screened by annual proctosigmoidoscopic examination, 17 (16 percent) had findings of chronic ulcerative colitis [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/9\" class=\"abstract_t\">9</a>]. Twelve underwent cholangiography, five of whom had features of primary sclerosing cholangitis.</p><p>Other conditions that have been associated with AIH include uveitis [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/10\" class=\"abstract_t\">10</a>], pernicious anemia [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/14\" class=\"abstract_t\">14</a>], Sj&ouml;gren's syndrome [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/14-16\" class=\"abstract_t\">14-16</a>], mixed connective tissue disease [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/17-19\" class=\"abstract_t\">17-19</a>], Weber-Christian panniculitis [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/20\" class=\"abstract_t\">20</a>], and CREST syndrome (calcinosis cutis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/21\" class=\"abstract_t\">21</a>]. There are also isolated associations with nonimmunologic diseases, including thrombotic thrombocytopenic purpura [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/14\" class=\"abstract_t\">14</a>] and sickle cell disease [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/22,23\" class=\"abstract_t\">22,23</a>]. </p><p>Among adult patients with AIH, age does not appear to have any impact on the prevalence of concurrent autoimmune disorders. A survey of AIH in older adults in the United Kingdom found no significant differences in the prevalence of concurrent immunologic disorders comparing patients aged &lt;60 years with those &gt;60 years [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/24\" class=\"abstract_t\">24</a>]. Similar findings have been reported from a Japanese group [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/12\" class=\"abstract_t\">12</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Type 2 AIH</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Disorders associated with type 2 AIH include diabetes mellitus, autoimmune thyroid disease, and vitiligo. In an early study of 65 patients with type 2 AIH, 22 had an associated autoimmune disease [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/25\" class=\"abstract_t\">25</a>]. The most common were type 1 diabetes mellitus, autoimmune thyroid disease, and vitiligo. More recent studies also show a variety of associated autoimmune diseases in type 2 AIH [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/2,3\" class=\"abstract_t\">2,3</a>]. Type 2 AIH has also been associated with a syndrome of vitiligo, nail dystrophy, and alopecia [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/26\" class=\"abstract_t\">26</a>], and with autoimmune polyglandular syndrome type I [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/27\" class=\"abstract_t\">27</a>]. Liver disease has been described in approximately 10 percent of patients with the last disorder, which is an autosomal recessive disease characterized by hypoparathyroidism, candidiasis, adrenal insufficiency, and gonadal failure (<a href=\"image.htm?imageKey=ENDO%2F67520\" class=\"graphic graphic_table graphicRef67520 \">table 3</a>). (See <a href=\"topic.htm?path=causes-of-primary-adrenal-insufficiency-addisons-disease\" class=\"medical medical_review\">&quot;Causes of primary adrenal insufficiency (Addison's disease)&quot;</a>.)</p><p>Anti-liver-kidney microsomal antibodies have been described in patients with autoimmune polyglandular syndrome type I and liver disease, and the hepatic autoantigens have been identified as the cytochrome P450 enzymes CYP2A6 and CYP1A2 [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/27\" class=\"abstract_t\">27</a>]. These differ from CYP2D6, the typical target for anti-LKM-1 in type 2 AIH. (See <a href=\"topic.htm?path=autoimmune-hepatitis-serologic-markers\" class=\"medical medical_review\">&quot;Autoimmune hepatitis: Serologic markers&quot;</a>.)</p><p>Type 2 AIH has also been reported in a patient with a genetically determined defect in immune tolerance associated with an autoimmune lymphoproliferative syndrome due to mutations of the <span class=\"nowrap\">Fas/Apo1/CD95</span> gene [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/28\" class=\"abstract_t\">28</a>].</p><p class=\"headingAnchor\" id=\"H74170266\"><span class=\"h1\">SPECIFIC DISORDERS</span></p><p class=\"headingAnchor\" id=\"H87993953\"><span class=\"h2\">Skin diseases</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin conditions may occur at various time points in the course of the disease. At initial presentation, rashes are seen in 8 to 17 percent of patients [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/24,29\" class=\"abstract_t\">24,29</a>]. The most common skin lesions include a pleomorphic maculopapular rash, particularly over the face, trunk, and upper arms. Associated skin lesions include psoriasis [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/29\" class=\"abstract_t\">29</a>], vitiligo [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/4,24,30\" class=\"abstract_t\">4,24,30</a>], urticaria [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/31\" class=\"abstract_t\">31</a>], impetigo [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/30\" class=\"abstract_t\">30</a>], acne [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/4,30\" class=\"abstract_t\">4,30</a>], lichen planus [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/31\" class=\"abstract_t\">31</a>], erythema nodosum [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/24,31\" class=\"abstract_t\">24,31</a>], prurigo nodularis [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/31\" class=\"abstract_t\">31</a>], pyoderma gangrenosum [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/32,33\" class=\"abstract_t\">32,33</a>], to vasculitis [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/30\" class=\"abstract_t\">30</a>]. Fever of unknown origin may also be associated with arthropathy and skin rashes [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/30\" class=\"abstract_t\">30</a>] and tends to resolve with immunosuppressive agents (<a href=\"image.htm?imageKey=GAST%2F59606\" class=\"graphic graphic_table graphicRef59606 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H74169962\"><span class=\"h2\">Celiac disease and immunoglobulin A (IgA) deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In practice, one of the most commonly identified associated conditions in AIH is celiac disease. The associated prevalence varies from 3 to 6 percent [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/34-36\" class=\"abstract_t\">34-36</a>]. In one study, the sera of 157 AIH-1 patients and 24 AIH-2 patients identified celiac disease in both types of AIH. This prevalence is eightfold higher than the incidence of the disease in a general population [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/35\" class=\"abstract_t\">35</a>]. Seventy-five percent of patients had no gastrointestinal symptoms. In a later study of 47 Italian patients with AIH, the prevalence of celiac disease was 6.4 percent [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/36\" class=\"abstract_t\">36</a>].</p><p>In a cohort study involving 460 patients with AIH from the Netherlands, the prevalence of celiac disease in adult patients with AIH was approximately 10 times higher than that in the general population (2.8 versus 0.35 percent) [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/37\" class=\"abstract_t\">37</a>]. The diagnosis was based on positive IgA tissue transglutaminase and endomysial antibodies. The majority of patients (95 percent) had AIH-1. There were no significant differences in the clinical features at presentation between patients with and without concomitant celiac disease. </p><p>In a systematic review and meta-analysis of nine studies with a total of 2046 pediatric patients, the pooled prevalence of celiac disease in children with AIH was 6.3 percent (95% CI 3.87-11.7) [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/38\" class=\"abstract_t\">38</a>]. Conversely, in children with celiac disease, the pooled prevalence of AIH was 1.4 percent (95% CI 0.84-2.15). In a separate study, patients with AIH associated with celiac disease who were on a gluten-free diet were more likely to achieve treatment-free sustained remission compared with patients with AIH without celiac disease (33 versus 8 percent), suggesting a possible long-term adjuvant effect of a gluten-free diet [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/39\" class=\"abstract_t\">39</a>]. Since a major complication of untreated celiac disease is malabsorption, awareness and early recognition of the clinical association between AIH and celiac disease are important and screening for celiac disease in AIH patients should be considered.</p><p class=\"headingAnchor\" id=\"H74170024\"><span class=\"h2\">IgA deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>IgA deficiency, defined as serum IgA levels &lt;0.07 <span class=\"nowrap\">g/L</span> with normal IgM and IgG levels in individuals &ge;4 years of age, is the most common primary immunodeficiency in Caucasians, with an estimated frequency of 1:600 [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/40\" class=\"abstract_t\">40</a>]. It has been shown to be associated with a variety of concomitant autoimmune diseases, including AIH. It is more prevalent in patients with AIH-2 and younger patients [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/13,41\" class=\"abstract_t\">13,41</a>].</p><p class=\"headingAnchor\" id=\"H74170319\"><span class=\"h1\">GENETIC RELATIONSHIPS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several observations have suggested a genetic influence on the relationship between autoimmune hepatitis (AIH) and other autoimmune conditions. In the original study defining type 2 AIH (AIH-2), 22 of 65 patients had other autoimmune diseases [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/25\" class=\"abstract_t\">25</a>]. The same autoimmune diseases were present in first-degree relatives from seven of the families. Similarly, in a study of type 1 AIH (AIH-1) and AIH-2 in children, autoimmune disorders were found in approximately 40 percent of first-degree relatives [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/13\" class=\"abstract_t\">13</a>].</p><p>The tendency for extrahepatic disorders may be associated with HLA-DR4. In a series of 122 patients with AIH-1, HLA-DR4 was more common in those with extrahepatic immunologic disease (62 versus 33 percent in those without extrahepatic disease) [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/5\" class=\"abstract_t\">5</a>]. A similar relationship was noted between HLA-DR4 and extrahepatic disease in patients with chronic viral hepatitis. A study from Brazil, where HLA associations differ from those in Europe and North America, showed no genetic predisposition to concurrent autoimmune diseases [<a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Several extrahepatic disorders associated with autoimmune hepatitis (AIH) have been described (<a href=\"image.htm?imageKey=GAST%2F59606\" class=\"graphic graphic_table graphicRef59606 \">table 1</a>). (See <a href=\"#H2\" class=\"local\">'Overview'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Common extrahepatic disorders associated with type 1 AIH are thyroiditis, Graves' disease, ulcerative colitis, celiac disease, and rheumatoid arthritis. (See <a href=\"#H3\" class=\"local\">'Type 1 AIH'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Common extrahepatic disorders associated with type 2 AIH are type 1 diabetes mellitus, autoimmune thyroid disease, and vitiligo. (See <a href=\"#H4\" class=\"local\">'Type 2 AIH'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The associated diseases may antedate the appearance of AIH or occur after the diagnosis of the liver disease is established.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The clinical expression of the associated disease can be extremely variable and, at times, may even be occult and unrecognized unless specifically sought.</p><p/><p class=\"headingAnchor\" id=\"H5993165\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The author and UpToDate would like to thank Dr. Edward Krawitt, who contributed to earlier versions of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/1\" class=\"nounderline abstract_t\">Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354:54.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/2\" class=\"nounderline abstract_t\">Bittencourt PL, Farias AQ, Porta G, et al. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J Clin Gastroenterol 2008; 42:300.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/3\" class=\"nounderline abstract_t\">Muratori P, Grnito A, Quarneto C, et al. Autoimmune hepatitis in Italy: The Bologna experience. J Hepatology 2009; 52:1210.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/4\" class=\"nounderline abstract_t\">Teufel A, Weinmann A, Kahaly GJ, et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 2010; 44:208.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/5\" class=\"nounderline abstract_t\">Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology 1993; 18:816.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/6\" class=\"nounderline abstract_t\">Abdo A, Meddings J, Swain M. Liver abnormalities in celiac disease. Clin Gastroenterol Hepatol 2004; 2:107.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/7\" class=\"nounderline abstract_t\">Caprai S, Vajro P, Ventura A, et al. Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin Gastroenterol Hepatol 2008; 6:803.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/8\" class=\"nounderline abstract_t\">Rubio-Tapia A, Abdulkarim AS, Wiesner RH, et al. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int 2008; 28:467.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/9\" class=\"nounderline abstract_t\">Perdigoto R, Carpenter HA, Czaja AJ. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol 1992; 14:325.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/10\" class=\"nounderline abstract_t\">Bloom JN, Rabinowicz IM, Shulman ST. Uveitis complicating autoimmune chronic active hepatitis. Am J Dis Child 1983; 137:1175.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/11\" class=\"nounderline abstract_t\">Abe M, Mashiba T, Zeniya M, et al. Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol 2011; 46:1136.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/12\" class=\"nounderline abstract_t\">Peng M, Li Y, Zhang M, et al. Clinical features in different age groups of patients with autoimmune hepatitis. Exp Ther Med 2014; 7:145.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/13\" class=\"nounderline abstract_t\">Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997; 25:541.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/14\" class=\"nounderline abstract_t\">Czaja AJ, Davis GL, Ludwig J, et al. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology 1983; 85:713.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/15\" class=\"nounderline abstract_t\">Biasi D, Caramasch P, Carletto A, et al. Sj&ouml;gren's syndrome associated with autoimmune hepatitis. A case report. Clin Rheumatol 1997; 16:409.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/16\" class=\"nounderline abstract_t\">Ecoiffier EB, Tubery M, Adoue D, et al. [Systemic manifestations of primary Gougerot-Sj&ouml;gren syndrome. Nature and incidence apropos of 34 cases]. Presse Med 1997; 26:995.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/17\" class=\"nounderline abstract_t\">Tomsic M, Ferlan-Marolt V, Kveder T, et al. Mixed connective tissue disease associated with autoimmune hepatitis and thyroiditis. Ann Rheum Dis 1992; 51:544.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/18\" class=\"nounderline abstract_t\">Wada T, Motoo Y, Ohmizo R, et al. Association of mixed connective tissue disease, Sj&ouml;gren's syndrome and autoimmune hepatitis: report of a case. Jpn J Med 1991; 30:278.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/19\" class=\"nounderline abstract_t\">Maeda M, Kanayama M, Hasumura Y, et al. Case of mixed connective tissue disease associated with autoimmune hepatitis. Dig Dis Sci 1988; 33:1487.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/20\" class=\"nounderline abstract_t\">Allen-Mersh TG. Weber-Christian panniculitis and auto-immune disease: a case report. J Clin Pathol 1976; 29:144.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/21\" class=\"nounderline abstract_t\">Ishikawa M, Okada J, Shibuya A, Kondo H. CRST syndrome (calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia) associated with autoimmune hepatitis. Intern Med 1995; 34:6.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/22\" class=\"nounderline abstract_t\">Chuang E, Ruchelli E, Mulberg AE. Autoimmune liver disease and sickle cell anemia in children: a report of three cases. J Pediatr Hematol Oncol 1997; 19:159.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/23\" class=\"nounderline abstract_t\">el Younis CM, Min AD, Fiel MI, et al. Autoimmune hepatitis in a patient with sickle cell disease. Am J Gastroenterol 1996; 91:1016.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/24\" class=\"nounderline abstract_t\">Al-Chalabi T, Boccato S, Portmann BC, et al. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 2006; 45:575.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/25\" class=\"nounderline abstract_t\">Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of &quot;autoimmune&quot; hepatitis. Hepatology 1987; 7:1333.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/26\" class=\"nounderline abstract_t\">Sacher M, Bl&uuml;mel P, Thaler H, Manns M. Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies. J Hepatol 1990; 10:364.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/27\" class=\"nounderline abstract_t\">Clemente MG, Meloni A, Obermayer-Straub P, et al. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 1998; 114:324.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/28\" class=\"nounderline abstract_t\">Pensati L, Costanzo A, Ianni A, et al. Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology 1997; 113:1384.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/29\" class=\"nounderline abstract_t\">Werner M, Prytz H, Ohlsson B, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol 2008; 43:1232.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/30\" class=\"nounderline abstract_t\">Mistilis SP, Blackburn CR. Active chronic hepatitis. Am J Med 1970; 48:484.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/31\" class=\"nounderline abstract_t\">Golding PL, Smith M, Williams R. Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med 1973; 55:772.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/32\" class=\"nounderline abstract_t\">Wat H, Haber RM. Trends in the Association between Pyoderma Gangrenosum and Autoimmune Hepatitis: Case Report and Review of the Literature. J Cutan Med Surg 2014; 18:345.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/33\" class=\"nounderline abstract_t\">Halac U, Al Dhaybi R, Powell J, et al. Unusual association between autoimmune hepatitis and severe pyoderma gangrenosum. J Pediatr Gastroenterol Nutr 2010; 50:219.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/34\" class=\"nounderline abstract_t\">Mirzaagha F, Azali SH, Islami F, et al. Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review. Dig Liver Dis 2010; 42:620.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/35\" class=\"nounderline abstract_t\">Volta U, De Franceschi L, Molinaro N, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 1998; 43:2190.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/36\" class=\"nounderline abstract_t\">Villalta D, Girolami E, Alessio MG, et al. Autoantibody Profiling in a Cohort of Pediatric and Adult Patients With Autoimmune Hepatitis. J Clin Lab Anal 2016; 30:41.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/37\" class=\"nounderline abstract_t\">van Gerven NM, Bakker SF, de Boer YS, et al. Seroprevalence of celiac disease in patients with autoimmune hepatitis. Eur J Gastroenterol Hepatol 2014; 26:1104.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/38\" class=\"nounderline abstract_t\">Vajro P, Paolella G, Maggiore G, Giordano G. Pediatric celiac disease, cryptogenic hypertransaminasemia, and autoimmune hepatitis. J Pediatr Gastroenterol Nutr 2013; 56:663.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/39\" class=\"nounderline abstract_t\">Nastasio S, Sciveres M, Riva S, et al. Celiac disease-associated autoimmune hepatitis in childhood: long-term response to treatment. J Pediatr Gastroenterol Nutr 2013; 56:671.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/40\" class=\"nounderline abstract_t\">Wang N, Shen N, Vyse TJ, et al. Selective IgA deficiency in autoimmune diseases. Mol Med 2011; 17:1383.</a></li><li><a href=\"https://www.uptodate.com/contents/autoimmune-hepatitis-associated-extrahepatic-disorders/abstract/41\" class=\"nounderline abstract_t\">Duchini A, McHutchison JG, Pockros PJ. LKM-positive autoimmune hepatitis in the western United States: a case series. Am J Gastroenterol 2000; 95:3238.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3678 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H6\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">OVERVIEW</a></li><li><a href=\"#H74170253\" id=\"outline-link-H74170253\">EFFECT OF AIH CLASSIFICATION</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Type 1 AIH</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Type 2 AIH</a></li></ul></li><li><a href=\"#H74170266\" id=\"outline-link-H74170266\">SPECIFIC DISORDERS</a><ul><li><a href=\"#H87993953\" id=\"outline-link-H87993953\">Skin diseases</a></li><li><a href=\"#H74169962\" id=\"outline-link-H74169962\">Celiac disease and immunoglobulin A (IgA) deficiency</a></li><li><a href=\"#H74170024\" id=\"outline-link-H74170024\">IgA deficiency</a></li></ul></li><li><a href=\"#H74170319\" id=\"outline-link-H74170319\">GENETIC RELATIONSHIPS</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H5993165\" id=\"outline-link-H5993165\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/3678|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/59606\" class=\"graphic graphic_table\">- Extrahepatic symptoms in AIH</a></li><li><a href=\"image.htm?imageKey=GAST/65135\" class=\"graphic graphic_table\">- Classification of autoantibodies in autoimmune hepatitis</a></li><li><a href=\"image.htm?imageKey=ENDO/67520\" class=\"graphic graphic_table\">- Polyglandular autoimmune syndromes</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=autoimmune-hepatitis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Autoimmune hepatitis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autoimmune-hepatitis-serologic-markers\" class=\"medical medical_review\">Autoimmune hepatitis: Serologic markers</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autoimmune-hepatitis-treatment\" class=\"medical medical_review\">Autoimmune hepatitis: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-of-primary-adrenal-insufficiency-addisons-disease\" class=\"medical medical_review\">Causes of primary adrenal insufficiency (Addison's disease)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-sclerosing-cholangitis-epidemiology-and-pathogenesis\" class=\"medical medical_review\">Primary sclerosing cholangitis: Epidemiology and pathogenesis</a></li></ul></div></div>","javascript":null}